Eastern Cooperative Oncology Group Phase II Trial of Lapatinib in Men With Biochemically Relapsed, Androgen Dependent Prostate Cancer

Urologic Oncology: Seminars and Original Investigations - United States
doi 10.1016/j.urolonc.2011.01.002
Full Text
Abstract

Available in full text

Categories
OncologyUrology
Date
Authors
Publisher

Elsevier BV

Related search

Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men With Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial

Clinical Cancer Research
Cancer ResearchOncology
2016English

Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer

Integrative Cancer Therapies
OncologyAlternative MedicineComplementary
2018English

Eastern Cooperative Oncology Group Performance Score Is Associated With Survival After Radiotherapy of Bone Metastases From Prostate Cancer

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2020English

Improving Bone Health in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: Results of a Randomized Phase 2 Trial

Cancer
Cancer ResearchOncology
2017English

Eastern Cooperative Oncology Group Experience With Chemotherapy in Advanced Non-Small Cell Lung Cancer

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1998English

Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596): A Trial of the Eastern Cooperative Oncology Group

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2009English

Lenalidomide Modulates IL-8 and Anti-Prostate Antibody Levels in Men With Biochemically Recurrent Prostate Cancer

Prostate
OncologyUrology
2011English

Phase III Clinical Trial of Thalidomide Plus Dexamethasone Compared With Dexamethasone Alone in Newly Diagnosed Multiple Myeloma: A Clinical Trial Coordinated by the Eastern Cooperative Oncology Group

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy